Citius pharmaceuticals, inc. (CTXR)
Income statement / Yearly
Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Dec'13Sep'13Dec'12Sep'12Sep'11
Revenues

-

-

-

0

0

0

0

0

0

0

0

Operating Expenses
Research and development

8,596

6,562

2,936

2,933

1,797

0

492

-

705

-

-

General and administrative

6,285

6,446

6,063

3,783

946

183

690

2

310

4

12

Stock-based compensation - general and administrative

715

779

986

732

486

470

0

-

-

-

-

Stock-based compensation - general and administrative

-

-

-

-

-

-

-

-

0

-

-

Professional Fees

-

-

-

-

-

-

-

25

-

15

13

Total Operating Expenses

15,598

13,789

9,986

7,449

3,229

653

1,182

28

1,016

19

25

Operating Loss

-15,598

-13,789

-9,986

-7,449

-3,229

-653

-1,182

-28

-1,016

-19

-25

Other Income (Expense)
Interest income

52

-

-

0

3

-

-

-

-

-

-

Gain on extinguishment of liability

-

450

-

0

-

-

-

-

-

-

-

Other income

-

818

-

0

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

0

0

-

0

-

-

Gain on revaluation of derivative warrant liability

-

-

452

-838

332

8

-

-

-

-

-

Gain (loss) on revaluation of derivative warrant liability

-

-

-

-

-

-

0

-

0

-

-

Interest expense

16

15

850

8

7

93

105

-

33

-

0

Total Other Income, Net

36

1,252

-398

-846

327

-83

-105

-

-33

-

-

Loss before Income Taxes

15,562

12,536

10,384

-8,295

-2,902

-737

-1,288

-

-1,049

-

-

Interest expense

-

-

-

-

-

-

-

3

-

2

-

Loss before provision for income taxes

-

-

-

-

-

-

-

-31

-

-22

-26

Income tax benefit

-

-

-

0

0

0

0

0

0

0

0

Net Loss

-15,562

-12,536

-10,384

-8,295

-2,902

-737

-1,288

-31

-1,049

-22

-26

Net Loss Per Share - Basic and Diluted

-0.77

-1.17

-1.89

-2.29

-1.37

-0.04

-0.07

-

-0.06

-

-

Weighted Average Common Shares Outstanding
Basic and diluted

20,161

10,731

5,482

3,623

2,122

19,322

17,757

-

16,888

-

-

Net income (loss) per share - basic (in Dollars per share)

-

-

-

-

-

-

-

0.00

-

0.00

0.00

Net income (loss) per share - diluted (in Dollars per share)

-

-

-

-

-

-

-

0.00

-

0.00

0.00

Weighted average shares outstanding - basic (in Shares)

-

-

-

-

-

-

-

18,000

-

18,000

18,000

Weighted average shares outstanding - diluted (in Shares)

-

-

-

-

-

-

-

18,000

-

18,000

18,000